June 8, 2017August 24, 2022
Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

The MEK inhibitor Mekinist (trametinib) is to be tested in combination with Opdivo (nivolumab) — or Opdivo plus Yervoy (ipilimumab) — in colorectal cancer ... Read more
June 6, 2017
Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Certain patients who underwent surgery for lymph-node positive colon cancer (stage 3) may require only three months of chemotherapy after surgery ... Read more
June 1, 2017June 1, 2017
Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

The MEK inhibitor binimetinib will soon be tested in combination with Opdivo (nivolumab) plus Yervoy (ipilimumab) in colorectal cancer patients ... Read more
May 30, 2017
PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

Trovagene’s PCM-075 therapy for several blood cancers and solid tumors, including colon cancer, proved safe in a Phase 1 clinical ... Read more
May 25, 2017May 25, 2017
FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Colorectal cancer patients with unresectable or metastatic tumors bearing a genetic feature — microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) — ... Read more
May 23, 2017
Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Overweight boys have a higher risk of developing colon cancer in adulthood, but if they lose the extra pounds by ... Read more
May 18, 2017May 18, 2017
Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Tom Marsilje, who survived stage IV colorectal cancer (CRC), has joined forces with New York-based Fight Colorectal Cancer to help patients search for ... Read more
May 16, 2017
Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

The Colon Cancer Coalition, a nonprofit organization that encourages grassroots efforts to promote colon cancer awareness and screening, is partnering ... Read more
May 11, 2017
Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

A new European project aims to develop an innovative endoscope device that can detect and diagnose colorectal cancer in its early ... Read more
May 9, 2017
Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

People who eat healthy, exercise, and do not smoke are less likely to report a personal history of colorectal cancer ... Read more
May 4, 2017May 4, 2017
RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

Small molecule compounds known as RLR agonists, being developed by Kineta to treat colon cancer, were seen to kill cancer ... Read more
May 2, 2017May 2, 2017
New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research

MIT researchers using the CRISPR-Cas9 genome editing and organoid technology have developed a new mouse model with a cancer that ... Read more

November 24, 2014November 24, 2014

Trovagene Reveals Results of Clinical Study for Detection of KRAS Mutations In Colorectal Cancer Patients

Trovagene, Inc., has announced the results of its clinical study evaluating the capacity of the company’s Precision Cancer Monitoring technology to detect and quantify KRAS mutations in the blood and urine ... Read more

November 21, 2014November 21, 2014

Study Finds Malaria Drug Could Aid In Colorectal Cancer Treatment

Researchers at St George’s, University of London, have developed a pilot study where they found artesunate, a common malaria drug, may aid in the treatment of colorectal cancer (CRC), and ... Read more

November 20, 2014November 20, 2014

Study Finds Financial Incentive Can Encourage Patients to Complete Colon Cancer Screening

A recent study titled “Financial Incentives for Completion of Fecal Occult Blood Tests among Veterans: A 2-Stage Pragmatic Cluster Randomized, Controlled Trial”, published in the journal Annals of Internal Medicine, showed ... Read more

November 19, 2014

PolypDx Recognized by Frost & Sullivan As A Screening Test for Early Detection of Colorectal Cancer

Frost & Sullivan, has preformed an analysis of the metabolomics-based diagnostic test market and recognized Metabolomic Technologies Inc. (MTI) with the 2014 North American Frost & Sullivan Award for Technology ... Read more

November 19, 2014November 19, 2014

Study Validates The 12-Gene Colon Cancer Recurrence Score For Prediction of Recurrence Risk in Rectal Cancer Patients

In a recent study titled “Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients”, published in the ... Read more

November 17, 2014November 17, 2014

Study Finds Link Between Colon Cancer Death Rates And Racial, Ethnic, Socioeconomic And Geographic Disparities

While the third leading cause of cancer-related deaths in the U.S used to affect mostly wealthy, white northerners, this trend has shifted, with the current populations at higher risk being poor, ... Read more

November 14, 2014

Study Finds KRAS Status Can Predict Time To Recurrence In Resected Stage III Colon Cancer

In a recent study titled “Prognostic value of KRAS mutations in stage III colon cancer: post-hoc analysis of the PETACC8 phase III trial dataset”, published in the journal Annals of ... Read more

November 13, 2014

Study Analyzes Healthy Lifestyle In Colorectal Cancer Prevention

A large European multisite study conducted by Krasimira Aleksandrova and colleagues, entitled “Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study” was published this week ... Read more

November 12, 2014

Study Finds Calcium Can Help Prevent Colorectal Cancer

In a news release authored by James Meschino, DC, MS, Director of Nutritional Therapies at the Canadian Integrative Cancer Immunotherapies Clinicin Toronto, the benefits from calcium intake in the prevention of colorectal cancer ... Read more

November 10, 2014November 10, 2014

Lycera Announces RORγ Oral Immunotherapy Efficient Against Colon Cancer Cells

Lycera Corp., a company developing breakthrough oral immune modulators, announced its latest data concerning the anti-tumor activity of synthetic RORγ agonist product candidates, during the Society for Immunotherapy of Cancer (SITC) ... Read more

November 7, 2014November 7, 2014

Study Finds TET1 Linked To Early Events In Colon Cancer Development

Results of a recent study titled “TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway” and published in the Oncogene journal, have shown ... Read more

November 6, 2014November 7, 2014

Study Finds Increased Incidence of Colorectal Cancer in Younger Patients

University of Texas MD Anderson Cancer Center researchers have published their latest results “Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010” in ... Read more

Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research